Furthermore, in pregnancies affected by preeclampsia, SSRI treatment was associated with significantly lower copeptin levels (Fig. 6, 657 ± 164 [n = 10] vs. 175 ± 134 ng/mL [n = 10], p = 0.04). The gene discussed is AVP; the disease is preeclampsia.